A set of isogenic iPSC lines by correcting the LRRK2 c.G6055A (p.G2019S) mutation in a PD patient-derived iPSC line using CRISPR/Cas9-based HDR or ABEs were established. This evidence concerns the gene LRRK2 and Parkinson disease.